Monitoring of Biomarkers by Portable Breath Gas Sensors: an Exploratory Study

Sponsor
University of Zurich (Other)
Overall Status
Completed
CT.gov ID
NCT02685241
Collaborator
Swiss Federal Institute of Technology (Other)
70
1
40
1.8

Study Details

Study Description

Brief Summary

Breath analysis is a non-invasive procedure to detect and monitor diseases and it is particularly attractive for patients who have to routinely check biomarkers, such as diabetics (blood glucose) or end-stage renal disease patients (creatinine). Preliminary data in a small study with healthy subjects showed a high correlation between blood glucose levels and acetone. Therefore, the objective of this study is to correlate biomarkers (glucose level and creatinine, respectively) with the corresponding target breath components (acetone and NH3, respectively) detected by portable gas sensors in the general population and to assess possible predictive models for biomarker estimations from the corresponding target breath component and predictive models to estimate abnormal biomarker concentrations.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Breath analysis is a non-invasive procedure to detect and monitor diseases and it is particularly attractive for patients who have to routinely check biomarkers, such as diabetics (blood glucose) or end-stage renal disease patients (creatinine). The proposed breath sensors analyse breath in real-time with on-line display of breath parameters, are portable, simple to operate, inexpensive and offer a sufficiently low limit of detection for the target breath markers, thus making them of high interest for daily clinical practice. Preliminary data in a small study with healthy subjects showed a high correlation between blood glucose levels and acetone.

    The primary objective of this study is to correlate biomarkers (glucose level and creatinine, respectively) with the corresponding target breath components (acetone and NH3, respectively) detected by portable gas sensors in the general population. The secondary objectives of the study are to assess possible predictive models for biomarker estimations from the corresponding target breath component and predictive models to estimate abnormal biomarker concentrations.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    70 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Monitoring of Biomarkers by Portable Breath Gas Sensors: an Exploratory Study
    Actual Study Start Date :
    Jun 1, 2016
    Actual Primary Completion Date :
    Oct 1, 2019
    Actual Study Completion Date :
    Oct 1, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    General population

    General population

    Outcome Measures

    Primary Outcome Measures

    1. The primary outcome will be the correlation between biomarkers (glucose levels and creatinine, respectively) and target breath components (acetone and NH3, respectively) detected by portable gas sensors [one hour, single measurement, no follow-up]

    Secondary Outcome Measures

    1. The assessment of possible predictive models for biomarker estimations (glucose levels and creatinine) from the corresponding target breath component (acetone and NH3) and predictive models to estimate the abnormal biomarker concentrations. [one hour, single measurement, no follow-up]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Informed consent

    • Age ≥ 18 years

    Exclusion Criteria:
    • Moribund or severe disease prohibiting protocol adherence

    • Physical or intellectual impairment precluding informed consent or protocol adherence

    • Pregnant patients

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Hospital Zurich, Division of Pneumology Zurich ZH Switzerland 8091

    Sponsors and Collaborators

    • University of Zurich
    • Swiss Federal Institute of Technology

    Investigators

    • Principal Investigator: Malcolm Kohler, MD, University of Zurich

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Malcolm Kohler, Prof. Dr. med., University of Zurich
    ClinicalTrials.gov Identifier:
    NCT02685241
    Other Study ID Numbers:
    • BASEC-Nr. PB-2016-00141
    First Posted:
    Feb 18, 2016
    Last Update Posted:
    Oct 18, 2019
    Last Verified:
    Oct 1, 2019
    Keywords provided by Malcolm Kohler, Prof. Dr. med., University of Zurich

    Study Results

    No Results Posted as of Oct 18, 2019